Product How it works Pricing Blog FAQ About Contact
Roivant Sciences

Roivant Sciences (NASDAQ: ROIV) net income

Roivant Sciences reported a net loss of $299.8m for fiscal 2026; in fiscal 2025 it reported a net loss of $172.0m. Earnings per share were −$0.43.

Roivant Sciences's best year of the last 6 was fiscal 2024. It reported a loss in 5 of those 6 years.

Net income, in millions of US dollars-809.22021-845.32022-1,00920234,3492024-172.02025-299.82026
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2026−$299.8m—−3,629.2%−$0.43
2025−$172.0m−104.0%−592.0%−$0.24
2024$4,349m—13,294.2%$5.55
2023−$1,009m—−3,200.2%−$1.42
2022−$845.3m—−1,528.9%−$1.26
2021−$809.2m—−3,400.9%—

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Roivant Sciences net income compared with its sector

By net income for its latest fiscal year, Roivant Sciences ranks 448th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Roivant Sciences, −3,629.2%.

RankCompanyNet incomeNet margin
446thMinerva Neurosciences−$293.4m—
447thVera Therapeutics−$299.6m—
448thRoivant Sciences−$299.8m−3,629.2%
449thPraxis Precision Medicines−$303.3m—
450thKymera Therapeutics−$311.4m−794.0%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of Roivant Sciences

How much did Roivant Sciences earn in fiscal 2026?
Roivant Sciences reported a net loss of $299.8m for fiscal 2026. In fiscal 2025 it reported a net loss of $172.0m.
What are the earnings per share of Roivant Sciences?
They were −$0.43 in fiscal 2026, compared with −$0.24 in fiscal 2025.
What was the most profitable year for Roivant Sciences?
Of its last 6 fiscal years, fiscal 2024, with $4,349m.
Where does Roivant Sciences rank in its sector by net income?
It ranks 448th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for Roivant Sciences come from?
From the annual report (Form 10-K) that Roivant Sciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Roivant Sciences files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021. More on Roivant Sciences: the Roivant Sciences page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.